Next |
home / stock / anip / anip message board
Subject | By | Source | When |
---|---|---|---|
Doesn't Look Good for the CVR's ... | auh2oman | investorshub | 05/12/2023 3:08:00 PM |
Thanks JTFM. Just for one last laugh, | silvr_surfr | investorshub | 05/12/2023 2:48:22 PM |
Silvr, here is an interesting study for Androgel. | Just the facts maam | investorshub | 05/12/2023 8:42:05 AM |
Novitium picked up approval for DEXAMETHASONE. | Just the facts maam | investorshub | 05/12/2023 12:36:43 AM |
Dasgrunt, looks like offering proceeds are not meant | Just the facts maam | investorshub | 05/12/2023 12:13:14 AM |
Easka, I agree it has been crazy. | Just the facts maam | investorshub | 05/11/2023 9:51:18 PM |
Dasgrunt, could be multiple activities. | Just the facts maam | investorshub | 05/11/2023 9:50:29 PM |
Public offering , and bidding on Akorn assests....... | dasgrunt | investorshub | 05/11/2023 9:00:46 PM |
This ticker has the strangest AH and per | Easka | investorshub | 05/11/2023 1:24:55 PM |
Thanks dasgrunt. | Just the facts maam | investorshub | 05/10/2023 10:36:48 PM |
https://www.youtube.com/watch?v=rpKKod4m34EANI PHARMACEUTICALS I | Just the facts maam | investorshub | 05/10/2023 10:35:57 PM |
Thanks Silvr, I agree that it likely won't | Just the facts maam | investorshub | 05/10/2023 10:18:26 PM |
Hi, here is a paper that was presented | silvr_surfr | investorshub | 05/10/2023 8:19:33 PM |
Guggenheim upgraded to $59.00 | dasgrunt | investorshub | 05/10/2023 2:40:38 AM |
Acthar sales dropped from $140.9 million in 2022 | Just the facts maam | investorshub | 05/10/2023 12:10:53 AM |
Thanks auh2oman. | Just the facts maam | investorshub | 05/09/2023 10:33:42 PM |
Silvr, it is hard to say what it | Just the facts maam | investorshub | 05/09/2023 10:13:09 PM |
Thanks JTFM. What do you think this | silvr_surfr | investorshub | 05/09/2023 12:23:29 PM |
Flurry of Upgrades This Morning ... | auh2oman | investorshub | 05/09/2023 12:01:21 PM |
According to 8-K filing, $ANIP's former Chairman of | Just the facts maam | investorshub | 05/09/2023 8:42:56 AM |
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.5...
BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ:ANIP) today announced that the Co...
BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2024 financial results on Friday, May 10, 2024, prior to the market open. Nikhil ...